Analyzing HALP and PNI scores as prognostic factors in metastatic head and neck cancers

Analyzing HALP and PNI scores as prognostic factors in metastatic head and neck cancers

Objective: This study investigates the prognostic significance of Hemoglobin, Albumin, Lymphocyte, Platelet (HALP) score and Prognostic Nutritional Index (PNI) in metastatic head and neck cancers. Methods: Retrospective analysis was conducted on data obtained from January 2014 to June 2022 for 68 pa...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yakup Duzkopru, Abdulkadir Kocanoglu, Mehmet Yigitbay, Ozlem Dogan, Hayriye Sahinli, Dogan Yazilitas
Format:	Article
Language:	English
Published:	Elsevier 2024-12-01
Series:	Asian Journal of Surgery
Subjects:	Biomarkers HALP score Head and neck cancer Prognosis Prognostic nutritional index
Online Access:	http://www.sciencedirect.com/science/article/pii/S1015958424007553
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Predictive Utility of the HALP and Modified HALP Score for the Assessment of Operative Complications in Patients Undergoing Laparoscopic Cholecystectomy for Acute Cholecystitis
by: Yasemin Keskin, et al.
Published: (2025-01-01)

Prognostic value of the HALP score in metastatic castration-resistant prostate cancer: an analysis combined with time to castration resistance
by: İvo Gökmen, et al.
Published: (2024-12-01)

Halp Score: A Simple and Easily Accessible Index for Predicting Prognosis in Colorectal Cancer Patients
by: Zeynep Güç
Published: (2022-10-01)

Predicting complicated acute diverticulitis with the HALP score: A retrospective study
by: Aziz Mutlu Barlas, et al.
Published: (2025-01-01)

CALLY index, but not HALP score, is associated with mortality in cirrhosis patients
by: Yıldız Günay, et al.
Published: (2025-01-01)

Does Delta Hemoglobin-Albumin-Lymphocyte Platelet (HALP) Score Predict the Risk of Early Progression in Patients Treated with CDK4/6 Inhibitors?
by: Burcu Belen GÜLBAĞCI, et al.
Published: (2024-12-01)

The preoperative hemoglobin, albumin, lymphocyte, and platelet score (HALP) as a prognostic indicator in patients with non-small cell lung cancer
by: Qiteng Liu, et al.
Published: (2024-11-01)

HALP Score in Predicting Response to Treatment in Patients with Early-Stage Gastric Cancer: A Multi-Centred Retrospective Cohort Study
by: Tolga Köşeci, et al.
Published: (2024-12-01)

Relationship Between Short‐Term Outcomes and PD‐L1 Expression Based on Combined Positive Score and Tumor Proportion Score in Recurrent or Metastatic Head and Neck Cancers Treated With Anti‐PD‐1 Antibody Monotherapy
by: Akihiro Ohara, et al.
Published: (2025-01-01)

Association between HALP (hemoglobin, albumin, lymphocyte, and platelet) score and poor outcomes in acute ischemic stroke patients with type 2 diabetes mellitus: a study from the Third China National Stroke Registry
by: Xu Zhu, et al.
Published: (2025-01-01)

Advancements in prognostic factors and survival outcomes following pulmonary metastasectomy for head and neck cancers
by: Konstantinos Grapatsas, et al.
Published: (2024-12-01)

Study of the association of the known prognostic variables with EGFR expression in head and neck squamous cell carcinomas
by: Toyaja Jadhav, et al.
Published: (2023-07-01)

Melioidosis in the head-and-neck region
by: Santosh Kumar Swain, et al.
Published: (2024-11-01)

Prognostic factors for head and neck cancer of unknown primary including the impact of human papilloma virus infection
by: Lars Axelsson, et al.
Published: (2017-06-01)

Comprehensive bioinformatic profiling of matrix metalloproteinases and their inhibitors: Expression and interaction patterns in head and neck cancer toward predictive biomarkers and personalized therapies
by: Rishaba Byju, et al.
Published: (2024-09-01)

Nomogram-derived immune-inflammation-nutrition score could act as a novel prognostic indicator for patients with head and neck squamous cell carcinoma
by: Wen-Yan Wang, et al.
Published: (2025-01-01)

Prognostic significance of hemoglobin, albumin, lymphocyte and platelet score in solid tumors: a pooled study
by: Jinze Li, et al.
Published: (2024-12-01)

Cetuximab Plus Methotrexate in Recurrent and/or Metastatic Head-and-Neck Squamous Cell Carcinoma
by: Wen-Chen Tang, et al.
Published: (2023-07-01)

Textbook of Head and Neck Anatomy /
by: Hiatt, James L., 1934-
Published: (2002)

Mucormycosis of the head and neck
by: Santosh Kumar Swain, et al.
Published: (2018-01-01)

Evaluation of Head and Neck Lymphadenopathies in Childhood
by: Elif Sinem Yazıcı, et al.
Published: (2024-01-01)

Pembrolizumab as first-line treatment for recurrent and metastatic head and neck cancer – real-world single-centre data
by: Bogdana Patachi, et al.
Published: (2025-01-01)

Exploring salivary gene expression clusters: A bioinformatics approach for advanced diagnosis and prognosis in head and neck squamous cell carcinoma
by: Rajesh Parsanathan, et al.
Published: (2024-06-01)

Extranodal tuberculosis of the head and neck
by: Santosh Kumar Swain, et al.
Published: (2018-01-01)

Pretreatment neutrophil–lymphocyte ratio as a prognostic factor in recurrent/metastatic head and neck cancer treated with pembrolizumab
by: Yuki Kasahara, et al.
Published: (2024-11-01)

Prognostic Factors of Liposarcoma in Head and Neck
by: Shuo DING, et al.
Published: (2025-01-01)

Evaluating a 14-week neck strengthening protocol for neuromuscular indicators associated with head and neck trauma
by: Lindsey Harn Schroeder, et al.
Published: (2025-01-01)

Clinical Benefits of Metronomic Chemotherapy in Platinum-Refractory, Recurrent, and Metastatic Head and Neck Squamous Cell Carcinoma
by: Amira Elwan, et al.
Published: (2025-01-01)

Screening of head neck cancer
by: Shrikant B. Mali
Published: (2024-03-01)

Virotherapy in Head and Neck Cancer
by: Zhan Wang
Published: (2024-03-01)

Marijuana and head and neck cancer: an epidemiological review
by: Michael Xie, et al.
Published: (2018-11-01)

The Effect of Exercise Intervention on Non-Specific Neck Pain and Head and Neck Angles Among Adult Smartphone Users
by: Sara Tabanfar, et al.
Published: (2025-01-01)

An Institutional Experience of Hematoma Management after Head-and-neck Oncosurgeries
by: Rajendra Dhondge, et al.
Published: (2024-12-01)

Salvage chemotherapy after progression on immunotherapy in recurrent/metastatic squamous cell head and neck carcinoma
by: Sandra Llop, et al.
Published: (2024-11-01)

Indian clinical practice consensus guidelines for the management of recurrent, persistent, or metastatic squamous cell carcinoma of head-and-neck - Update 2023
by: Vanita Noronha, et al.
Published: (2024-11-01)

Editorial: The role of the microbiome in head and neck cancer
by: Fabio Cumbo, et al.
Published: (2025-01-01)

Association between dental exams and diagnosis of head and neck cancer
by: Nadia Alexandra Debick, et al.
Published: (2022-09-01)

Cutaneous angiosarcoma of head and neck: Case report and literature review
by: Juliana Maria Rodrigues Sarmento Pinheiro, et al.
Published: (2023-09-01)

Sleep Quality in Head and Neck Cancer
by: Giancarlo Pecorari, et al.
Published: (2024-11-01)

ASSOCIATION OF TEXT NECK WITH THE APPEARANCE OF NECK PAIN: SYSTEMATIC REVIEW
by: Maria Vanessa dos Santos Costa, et al.
Published: (2024-11-01)